|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8900 EUR | +0.23% |
|
-2.20% | -42.06% |
| 06-10 | AB Science presents new data on Masitinib |  |
| 05-17 | AB Science S.A. announced that it has received $2.989368 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Specialty & Advanced Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 78.32M | - | - | - | - | |
| 67.84B | |||||
| 8.39B | |||||
| 7.92B | |||||
| 4.53B | |||||
| 3.72B |
- Stock Market
- Stocks
- AB Stock
- Charts AB Science
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
